喘时的三重吸入疗法:信念,行为和怀疑
D Bagnasco1, I Ansotegui2, I Baiardini1
1Respiratory Diseases and Allergy Department, IRCCS Polyclinic Hospital San Martino, Genoa, Italy; Department of Internal Medicine (DiMI), University of Genoa, Italy.
Pulmonary pharmacology & therapeutics
|November 21, 2024
概括
吸入式三重疗法 (ICS-LABA-LAMA) 在喘管理中未得到充分利用,尽管有证明的好处. 一项调查揭示了其应用方面的专业不确定性,表明需要更好地将研究纳入实践.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 临床实践 临床实践
背景情况:
- 根据GINA指导方针,长效肌肉抗剂 (LAMA) 与吸入性皮质类固醇 (ICS) 和长效β-2激动剂 (LABA) 结合,代表了喘的先进治疗选择.
- 尽管已确立有效性和安全性,但吸入式三重疗法 (ITT) 在喘专家中受到了有限的采用.
研究的目的:
- 调查喘专家关于使用吸入式三重疗法 (ITT) 的信念和行为.
- 确定影响ITT在喘管理中的处方模式和临床定位的因素.
主要方法:
- 由Interasma科学网络 (INESnet) 专家开发了一项特设调查,通过Delphi轮进行了改进.
- 该问卷通过社交媒体在国际上分发 (2023年6月至9月),并使用描述性统计和斯皮尔曼非参数测试进行分析.
- 314个已填写的问卷提供了临床医生对ITT态度的数据.
主要成果:
- 只有35.7%的专家认为ITT是主要的治疗选择,61.8%认为它是高剂量ICS-LABA之后的二线选择.
- 显著多数 (89.2%) 同意,优化吸入疗法应该先于使用生物制剂.
- 持续的空气流限制和高可逆性被确定为对ITT反应的预测因素.
结论:
- 喘专家认为ITT是治疗持续性喘的重要工具.
- 尽管人们意识到其在减少恶化和改善肺功能方面的好处,但关于其最佳临床定位的不确定性仍然存在.
- 需要进一步的举措来弥合研究成果和日常临床实践之间的差距,以便有效地整合ITT.
相关概念视频
Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


